SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 117 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290,400 | -30.6% | 20,000 | 0.0% | 0.09% | -31.8% |
| Q2 2023 | $418,600 | -79.8% | 20,000 | -81.5% | 0.13% | -79.8% |
| Q2 2022 | $2,075,000 | +17.7% | 107,852 | +6.3% | 0.64% | -12.5% |
| Q1 2022 | $1,763,000 | -19.5% | 101,447 | +1.4% | 0.73% | -17.7% |
| Q4 2021 | $2,189,000 | +267.3% | 100,000 | +188.0% | 0.89% | +233.5% |
| Q2 2021 | $596,000 | +33.3% | 34,727 | +73.6% | 0.27% | +9.0% |
| Q1 2021 | $447,000 | -33.0% | 20,000 | -33.3% | 0.24% | -37.1% |
| Q4 2020 | $667,000 | – | 30,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |